BABUK GHUMAN: Open Payments
NPI 1487699310 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 15 payments from 6 companies in 2025. Trend: 2023 $363 · 2024 $670 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 8 | $301 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $37 |
| IBSA Pharma Inc. | 1 | $21 |
| SCILEX PHARMACEUTICALS INC. | 1 | $20 |
| Radius Health, Inc. | 1 | $14 |
Products named: PROLATE, XTAMPZA, QULIPTA, TANLOR, Tirosint, ZTLido, Tymlos.
Industry payments across NV — which companies pay providers there.
